Fundz

Pharmazz reported raising $7.5 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEAug 30, 2024

Amount Raised

$7.5 Million

$7.5 Million sold, per SEC Form D (first sale Aug 15, 2024)

Round Type

Venture

WillowbrookBiotechnologyHealthcareHealth Care

Who to call at Pharmazz, and when

A new round usually means Pharmazz is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pharmazz raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pharmazz, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pharmazz

Location

50 W 75TH ST

Willowbrook, Illinois, United States

About

Pharmazz is a privately held company developing novel products in critical care medicine. The U.S. Food and Drug Administration (FDA) has approved two phase III INDs for Centhaquine as an agent for hypovolemic shock and Sovateltide for cerebral ischemic stroke. In addition, Pharmazz obtained marketing authorization for two of its first-in-class drug molecules, Centhaquine and Sovateltide, for hypovolemic shock and ischemic stroke, respectively, in India. Pharmazz has partnered with Sun Pharmaceutical to market Sovateltide for cerebral ischemic stroke patients in India. In addition, Pharmazz has partnered with Dr. Reddy's Laboratories to market Centhaquine, a resuscitative agent, in India.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pharmazz raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsManish, Managing Director hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pharmazz's next move

See what Strategic adds

Pharmazz raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.